BrainsWay

BrainsWay

Health Care Equipment & Supplies
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

$350.3M

Market Cap • 11/19/2026

2006

(20 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Israel

Israel

Country

Valuation

P/B

4,3

P/S

5,4

P/EBITDA

32,9

P/OCF

27,2

P/FCF

27,2

P/E

34,9

BVPS

2

EPS

0,3

Market Cap

Market Cap

350,3M

EV

294M

EV/Revenue

4,5

EV/EBITDA

27,6

EV/EBIT

33

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-83,6M

Profitability

Gross Margin

76,1%

EBITDA Margin

16,3%

EBIT Margin

13,6%

Net Margin

15,5%

D&A/EBITDA

0%

R&D/Revenue

18,6%

Capex/Revenue

0%

Capex/D&A

0,6%

Capex/OCF

0,1%

SBC/OCF

16,3%

% PPE

10,3%

% Goodwill

0%

ROE

13,3%

ROIC

23,2%

Growth

CAGR Revenue 5Y

18,3%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,9

Quick Ratio

2,5

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium